Literature DB >> 19155773

European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions.

Markus P Schlaich1, Guido Grassi, Gavin W Lambert, Nora Straznicky, Murray D Esler, John Dixon, Elisabeth A Lambert, Josep Redon, Krzysztof Narkiewicz, Jens Jordan.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19155773     DOI： 10.1097/HJH.0b013e32831dafaf

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  10 in total

Review 1.  The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension.

Authors:  Revathy Carnagarin; Cynthia Gregory; Omar Azzam; Graham S Hillis; Carl Schultz; Gerald F Watts; Damon Bell; Vance Matthews; Markus P Schlaich
Journal:  Curr Hypertens Rep       Date:  2017-10-28       Impact factor: 5.369

2.  "Broken" autonomic cardiac circadian clock in obese adolescents: evidence and implications.

Authors:  Guido Grassi
Journal:  Clin Auton Res       Date:  2014-11-01       Impact factor: 4.435

3.  Cardiovascular endocrinology: tailoring antihypertensive drug treatment to body size.

Authors:  Guido Grassi; Giuseppe Mancia
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

4.  Obesity-induced increases in sympathetic nerve activity: sex matters.

Authors:  Virginia L Brooks; Zhigang Shi; Seth W Holwerda; Paul J Fadel
Journal:  Auton Neurosci       Date:  2014-11-20       Impact factor: 3.145

5.  Hypertension and obesity: correlates with renin-angiotensin-aldosterone system and uric acid.

Authors:  Gema Ruiz-Hurtado; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-06-23       Impact factor: 3.738

6.  Prognostic value of obesity on both overall mortality and cardiovascular disease in the general population.

Authors:  Isabel Ponce-Garcia; Marta Simarro-Rueda; Julio Antonio Carbayo-Herencia; Juan Antonio Divisón-Garrote; Luis Miguel Artigao-Ródenas; Francisco Botella-Romero; Antonio Palazón-Bru; Damian Robert James Martínez-St John; Vicente Francisco Gil-Guillén
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

7.  Olmesartan/amlodipine/hydrochlorothiazide in obese participants with hypertension: a TRINITY subanalysis.

Authors:  Eli M Roth; Suzanne Oparil; Michael Melino; James Lee; Victor Fernandez; Reinilde Heyrman
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-06-04       Impact factor: 3.738

8.  Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naïve Type 2 Diabetes following Equivalent Weight Loss.

Authors:  Nora E Straznicky; Mariee T Grima; Carolina I Sari; Elisabeth A Lambert; Sarah E Phillips; Nina Eikelis; Justin A Mariani; Daisuke Kobayashi; Dagmara Hering; John B Dixon; Gavin W Lambert
Journal:  Front Physiol       Date:  2016-11-03       Impact factor: 4.566

9.  Regulation of alternative splicing in obesity-induced hypertension.

Authors:  Zodwa Dlamini; Rodney Hull; Tshepiso J Makhafola; Mzwandile Mbele
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-28       Impact factor: 3.168

10.  Decreased circulating T regulatory lymphocytes in obese patients undergoing bariatric surgery.

Authors:  Claudia Agabiti-Rosei; Valentina Trapletti; Silvia Piantoni; Paolo Airò; Angela Tincani; Carolina De Ciuceis; Claudia Rossini; Francesco Mittempergher; Amin Titi; Nazario Portolani; Stefano Caletti; Maria Antonietta Coschignano; Enzo Porteri; Guido A M Tiberio; Paola Pileri; Leonardo Solaini; Rajesh Kumar; Silvia Ministrini; Enrico Agabiti Rosei; Damiano Rizzoni
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.